Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Latest News
All News
EMJ GOLD
HonorHealth hires longevity expert Nicholas Schork
EMJ GOLD
AstraZeneca and Viseven win 2025 HBA ACE Awards
EMJ GOLD
AbbVie invests $195m in US expansion ahead of tariffs
EMJ GOLD
Bayer deal caps big week for pancreatic cancer research
Latest Articles
All Articles
EMJ GOLD
5 minutes with Dr Henar Hevia, J&J Innovative Medicine
Henar Hevia, Senior Director, EMEA Therapeutic Area Lead, Oncology, reveals what it’s like to work in oncology today, especially at J&J.
EMJ GOLD
BMS’ Emma Charles on access, impact and inclusion
Emma shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and fairer in Europe.
EMJ GOLD
Pharma’s role in the rise of wellness misinformation
Wellness trends are outpacing science and endangering lives. As trust in traditional medicine erodes, pharma must step in to correct the narrative.
EMJ GOLD
5 minutes with Graham Clark, CEO, Phastar
Graham Clark, CEO, Phastar, explores the current state of play in clinical research, the future of AI in the field and values-based business.
Latest Podcasts
All Podcasts
EMJ GOLD
Season 10’s insights, inspiration and ‘aha’ moments
Listen in to the standout moments from EMJ GOLD’s guests this season, uncovering the challenges and opportunities shaping today’s pharmaceutical industry.
EMJ GOLD
Bayer's Dr Joana Reis on the promise of AI in breast cancer
Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in radiology today.
EMJ GOLD
AbbVie's Dr Daejin Abidoye on community and compassion in cancer care
AbbVie’s Daejin Abidoye reflects on his 20-year journey in oncology – from clinical insights to advances in precision medicine in the cancer space.
EMJ GOLD
Chiesi's Shish Patel on COPD, the climate and improving care
What is the environmental cost of respiratory illness? In this episode, Shish Patel, Medical Director, Chiesi UK joins Isabel to explore this and COPD’s rising burden.
Latest Infographics
All Infographics
EMJ GOLD
What HCPs want: Why interactive medical content works
EMJ GOLD
How HCPs consumed medical content in 2024
EMJ GOLD
Fostering trust between pharma and HCPs
EMJ GOLD
The rise, fall and smart allocation of pharma marketing budgets
We’ve noticed you’re accessing
from
North/South America.
View
View